Atherosclerotic Plaque Detection via IVUS 应用 IVUS 检测动脉粥样硬化斑块 Fudan University, Zhongshan Hospital Shanghai Institute of CVD CIT 2010 Juying Qian, MD, FACC.

Slides:



Advertisements
Similar presentations
Reversing Atherosclerosis with Aggressive Lipid Lowering Reversing Atherosclerosis with Aggressive Lipid Lowering Presented at American Heart Association.
Advertisements

MRI and MRA of the Carotid Arteries
Atherosclerosis Mike Clark, M.D.. Terms Arteriosclerosis – hardening of the arteries Atherosclerosis – a form of arteriosclerosis Venosclerosis Arteriolosclerosis.
IVUS-VH & Vulnerable Plaque Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon City, S. Korea Jang-Ho Bae, MD., PhD. Heart Center.
Atherosclerosis.
Pathogenesis of Acute Coronary Syndromes Nathan Wong
BY Dr Ola Omran Pathology Department. objectives 1.Define & classify Arteriosclerosis 2.Emphasize the clinical importance of the arteriosclerosis 3.List.
Stents Are Not Enough: Statins Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford.
Beyond CAG- IVUS and FFR Dr Frijo Jose A. CAG – Extensively used – Entire cor anatomy, including small & distal vessels – Helpful in clinical decision.
Tasneem Z Naqvi, MD, FRCP (UK), RVT, MMM Director Non-invasive Cardiology and Echocardiography Professor of Medicine and Clinical Scholar Keck School of.
流态化 概述 一、固体流态化:颗粒物料与流动的流体接触,使颗粒物料呈类 似于流体的状态。 二、流态化技术的应用:流化催化裂化、吸附、干燥、冷凝等。 三、流态化技术的优点:连续化操作;温度均匀,易调节和维持; 气、固间传质、传热速率高等。 四、本章基本内容: 1. 流态化基本概念 2. 流体力学特性 3.
导体  电子导体  R   L  i 离子导体  ( 平衡 ) mm   .
Types of blood vessels: Veins Arteries Common structures Tunica adventitia Tunica media Tunica intima Lumen.
ASTEROID A Study To evaluate the Effect of Rosuvastatin On Intravascular ultrasound- Derived coronary atheroma burden.
Reference: Circulation Journal 2009; 73(11): Circulation journal : official journal of the Japanese Circulation Society AZT-CRES Jan-2010.
ASTEROID A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden   References Nissen et al. Effect.
Atherosclerosis.
Heart disease. Aim To review cardiac cycle with an exam question To understand how atheroma and thrombosis can lead to heart attacks To learn what an.
BackgroundBackground HDL-C levels are inversely related to CV event rates. HDL-C levels are inversely related to CV event rates. Torcetrapib, a cholesteryl.
Ultrasound Principles
Copyright ©2013 American Heart Association INTRAVASCULAR ULTRASOUND Sripal Bangalore, M.D., M.H.A. and Deepak L. Bhatt, M.D., M.P.H., F.A.H.A.
Navigating the Coronary Circulation: Angiography vs IVUS Pearls and Pitfalls Philippe L. L’Allier, MD Montreal Heart Institute Tuesday, March 27, 2007.
Associate professor of pathology
Virtual Histology:From Theory to Vulnerable Plaque Detection Shaoliang Chen MD Nanjing First Hospital Nanjing Cardiovascular Hospital.
Atherosclerosis CVS 1 Hisham Al Khalidi. Atherosclerosis.wmv.
When I Use IVUS Neal Uren MD FRCP Consultant Cardiologist Royal Infirmary Edinburgh.
1 物体转动惯量的测量 南昌大学理学院
动物的激素调节 大庆石油高级中学 怀颖. 一、动物的激素调节: 复习:体液的组成? 体液调节概念: 象激素、 CO2 、 H+ 、乳酸和 K+ 等通过体 液传送,对人和对动物的生理活动所进行的 调节称为体液调节,而激素相对于这些化学 物质的调节最为重要。
血管内超声基本知识 浙江大学医学院附属第二医院 心内科 项美香.
2015 年江苏省美术专业统考考试说明 解读 : 贡加兵 扬州市邗江区公道中学
Atherosclerosis CVS lecture 2 Atherosclerosis. Vessel wall structure.
Dr.Hesham Rashid, MD PATHOGENIC MECHANISMS OF ATHEROSCLEROSIS
Fu Wai Hospital Jie Qian
Aortic and Carotid Magnetic Resonance Image (MRI) Imaging
Progression, Regression, and Remodeling of Atherosclerosis ( 동맥경화증의 진행, 퇴축, 그리고 재성형 ) Hyo-Soo Kim, MD, PhD Cardiovascular Center, Seoul National University.
Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:
New techniques for the “invasive diagnosis” of the vulnerable plaque Antwerp, 17 March 2006.
VBWG Growth in heart disease, 2000–2050 Deaths Population Foot DK et al. J Am Coll Cardiol. 2000;35:
Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:
VASCULAR DISEASE Atherosclerosis Jagdish Butany,MBBS,MS,FRCPC, Prof. Dept Lab Med & Pathobiol., Pathologist, UHN-Toronto Gen/Hosp
Slide Source: Lipids Online Slide Library Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Nissen SE et al. JAMA.
순환기질환 - 혈관, 림프관 -.
Topic Report Sensitivity and Specificity for OCT Diagnosis Advisor: Sheng-Lung Huang Speaker: Yao - Sheng Lin.
1 Atherosclerosis ISCHEMIC CHEART DISEASE. 2 Atherosclerosis ATHEROSCLEROSIS IS THE CHRONIC DISEASE WITH THE LIPID AND PROTEIN ABNORMAL METABOLISMS, WITH.
IVUS in Peripheral Procedures
Clinical Trial Results. org ILLUSTRATE Presented at the American College of Cardiology Annual Scientific Session March, 2007 Presented by Dr. Steven E.
Mild degree of coronary athersclerosis
Veins and Arteries Smooth muscle: no striations, uninucleated, spindle shaped cells.
Stephen J Nicholls MBBS PhD FRACP FACC
Should we Use OCT in STEMI Patients?
Treatment LDL-C: baseline (mg/dL) LDL-C: 24 mo (mg/dL) p
Circ Cardiovasc Imaging
The following slides highlight a report on presentations from the Late-Breaking Clinical Trial Sessions and a Satellite Symposium at the 76th Annual Scientific.
Diagnosis of Atherosclerosis by Imaging
Jacques Kpodonu, MD, Venkatesh G. Ramaiah, MD, Edward B. Diethrich, MD 
Chapter 12 Pathophysiology of Atherosclerosis
Arterial wall: structure and function
VW-MR imaging to differentiate among causes of intracranial arterial stenosis when angiography findings are inconclusive. VW-MR imaging to differentiate.
Section 4: Plaque dynamics and stenosis
In vivo human comparison of intravascular ultrasonography and angiography  Marwan Tabbara, MD, Rodney White, MD, Douglas Cavaye, FRACS, George Kopchok,
Bioresorbable Vascular Scaffolds in Cardiac Allograft Vasculopathy: A New Therapeutic Option  Flavio Ribichini, MD, Michele Pighi, MD, Giuseppe Faggian,
B-mode ultrasound measurement of the distance between the line indicated by Arrow 1 (lumen-intima interface) and the line marked by Arrow 2 (media-adventitia.
Flow of Patients Through the Trial
Douglas M. Cavaye, FRACS, Rodney A. White, MD, George E
Baseline Characteristics, Blood Pressures, and Laboratory Values
Coronary angiography in the right caudal view demonstrating a severe concentric stenosis in the left circumflex artery (*). Coronary angiography in the.
Charis Costopoulos et al. JIMG 2017;10:
James A. Goldstein et al. JIMG 2008;1:
Presentation transcript:

Atherosclerotic Plaque Detection via IVUS 应用 IVUS 检测动脉粥样硬化斑块 Fudan University, Zhongshan Hospital Shanghai Institute of CVD CIT 2010 Juying Qian, MD, FACC

Limitation of Coronary angiogram Focal lesion Diffuse lesion D% silhouette 50% Lower accuracy of quantitative assessment Little information of the plaque characteristics angiogram Positive remodeling

Coronary angiogram & IVUS

Volcano intravascular ultrasound BSC mechanical Phased array

Normal coronary artery The relationship between IVUS three layer and the biological intima, media and adventitia Intima is dense and will appear as a “white” layer between the media and the blood speckles. Adventitia is composed of collagen that highly reflected by ultrasound (appears white) Media is made of homogeneous smooth muscle cells and is not reflected by ultrasound (appears dark)

Normal coronary artery IVUS three layer does not equal to the biological intima, media and adventitia Abdomial aortic dissection

IVUS classcification of atherosclerosis Type I or II Initial lesion or fatty streak Stage I or II

IVUS classcification of atherosclerosis Type III Pre-atheroma Stage III

IVUS classcification of atherosclerosis Type IV atheroma Stage IV

IVUS classcification of atherosclerosis Type Va fibro-atheroma Stage V

Type Vb IVUS classcification of atherosclerosis fibro-atheroma Stage V

Type Vc IVUS classcification of atherosclerosis fibro-atheroma Stage V

IVUS classcification of atherosclerosis Type VIa: Plaque rupture or erosion complicated lesions Stage VI

IVUS classcification of atherosclerosis Type VIb: hematoma complicated lesions Stage VI

IVUS classcification of atherosclerosis Type VIc: thrombus complicated lesions Stage VI

IVUS classcification of atherosclerosis

Qualitative assessment Eccentric (>0.5)Concentric(<0.5) Eccentric index=0.45 Eccentric index= (atheroma thickness)max (atheroma thickness)max-(atheroma thickness)min Eccentric index=0.67 atheroma eccentricity

Qualitative assessment Atheroma morphology Soft plaqueFibrous plaque Calcified plaque

Qualitative assessment Thrombus Atheroma morphology

Qualitative assessment Unstable lesion plaque rupture and ulceration Contrast media

Characteristics of vulnerable plaue in IVUS :  Area of echolucent zone>1mm 2 ;  Echolucent area/plaque area >20 %;  Thickness of fibrous cap <0.7mm 。 Ge et al, Heart, 1999 Vulnerable plaque

Qualitative assessment pseudoaneurysm

Myocardial bridging: half-moon echolucent zone Systolic diastolic Qualitative assessment

Quantitative measurement Border indentification EEM Edge of intima

Quantitative measurement Lumen-csa=3.8mm2 Max Lumen D=2.4mm Min lumen D=2.1mm lumen Lumen area stenosis(%) = reference lumen-csa - lumen-csa reference lumen-csa

Quantitative measurement EEM-csa=14.2mm 2 Lumen-csa=3.8mm 2 EEM measurement Atheroma (plaque+media) area =( )mm 2 =10.4mm 2 Plaque burden=10.4/14.2=73.2%

Quantitative measurement Calcium measurement 95° 150° 240°

Realtime 3D IVUS imaging

29 Calculation of plaque volume by IVUS Proximal Fiduciary Site Distal Fiduciary Site Proximal Fiduciary Site Distal Fiduciary Site Images Courtesy of Cleveland Clinic Intravascular Ultrasound Core Laboratory

Virtual Histology-IVUS

31 REVERSAL : primary endpoint –change of total plaque volume * 与基线相比进展 (P=0.001). † 与基线相比无变化 (P=0.98). Nissen SE et al. JAMA. 2004;291: P=0.02 总斑块体积变化百分比 普伐他汀 40 mg 阿托伐他汀 80 mg % 变化百分比

ESTABLISH Trial: atorvastatin 20mg baseline 6m FU Okazaki S, et al. Circulation. 2004; 110: m FU baseline Control atorvastatin

33 ESTABLISH : change of plaque volume by IVUS *P< Okazaki S et al. Circulation. 2004:110: * * 绝对变化 (mm 3 ) 阿托伐他汀 20 mg 常规治疗 (%) LDL 自基线变化百分比 斑块体积绝对变化 (%) 斑块体积变化百分比 变化百分比 (%)

34 GAIN :斑块体积的变化 P=0.19 治疗 1 年后斑块体积的绝对变化 (mm 3 ) Schartl M et al. Circulation. 2001;104: 斑块体 积的变 化 (mm 3 )

斑块体积高回声团块 ( 纤维斑块 ) 低回声团块 ( 富含脂质的斑块 ) 治疗 1 年后的平均变化 (%) * 10.1 阿托伐他汀 mg 常规治疗 高回声团块是斑块更稳定的标 志. 更多的高回声团块代表斑块 更稳定 GAIN :斑块内容物的变化 *P=0.021 Schartl M et al. Circulation. 2001;104: 治疗 1 年后斑块内容物变化百分比 (%)

Thanks